Many solid cancers come with an extended CD44+/hi/CD24?/low cancers stem cell (CSC) population, that are relatively chemoresistant and get recurrence and metastasis. e.g., HER2+ and basal/triple-negative subtypes, possess a worse prognosis with an increase of prices of recurrence and metastasis, most likely because of an extension of cancers stem cells (CSCs), additionally known as tumor-initiating… Continue reading Many solid cancers come with an extended CD44+/hi/CD24?/low cancers stem cell